六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 1.02, 5.02, and 9.01 Accession Number: 0001437749-21-008214 Act: 34 Size: 132 KB 网页链接
$Aytu BioPharma(AYTU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001567619-21-007275 Size: 4 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001319244-21-000184 Act: 34 Size: 128 KB 网页链接
$Aytu BioPharma(AYTU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001567619-21-006990 Size: 4 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001437749-21-006896 Act: 34 Size: 19 KB 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-21-016776 Act: 34 Size: 755 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01, 2.01, 2.03, 5.02, 5.03, 5.07, 8.01, and 9.01 Accession Number: 0001213900-21-016775 Act: 34 Size: 755 KB 网页链接
$Aytu BioScience(AYTU)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-21-000116 Act: 34 Size: 60 KB 网页链接
$Aytu BioScience(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-002627 Act: 34 Size: 7 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-002591 Act: 34 Size: 315 KB 网页链接